Freda Pharmaceutical

Shandong Freda Pharmaceutical Group Co., Ltd., relying on Shandong Academy of Pharmaceutical Sciences for technical support, is committed to the development of pharmaceuticals, health foods, and cosmetics related to human health, forming an integrated pharmaceutical research and development institution combining science, industry, and trade.
The pharmaceutical group has successively established multiple high-tech enterprises, including Shandong Bausch & Lomb (formerly Zhengda) Freda Pharmaceutical Co., Ltd., Shandong Freda Biopharmaceutical Co., Ltd., Shandong Mingren Freda Pharmaceutical Joint-Stock Co., Ltd., Shandong Freda Bioengineering Co., Ltd., and Shandong Freda Biotechnology Co., Ltd., leveraging its proprietary intellectual property technologies. The industries involved cover pharmaceuticals, health foods, cosmetics, medical devices, and APIs, boasting well-known brands such as 'Runshu', 'RunJie', 'Shipeite', 'Mingren', and 'Yilian'. In 2012, Freda Pharmaceutical Group achieved sales revenue of 2.08 billion yuan and profits and taxes of 0.4 billion yuan. Among them, Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd. has developed into the leading ophthalmic pharmaceutical production base in China, ranking among the top 100 pharmaceutical industrial enterprises in China and the top 50 industrial enterprises in Jinan, and has been rated as one of the top ten enterprises in terms of efficiency in key national industries and among the top 100 taxpayers in Shandong Province. Its products have captured a 20% market share in the domestic ophthalmic pharmaceutical market. Shandong Freda Biopharmaceutical Co., Ltd., leveraging its technological advantages in producing hyaluronic acid through fermentation, has not only secured a major market share in the domestic market but also exported its products to international markets such as Japan, the United States, Europe, and South Korea.
The pharmaceutical group has established a pharmaceutical business division and a cosmetics business division, with a comprehensive sales network and customer service system nationwide. It emphasizes professional academic promotion and marketing, cultivates a highly professional sales team, and integrates resources of its subsidiaries, including traditional Chinese patent medicines, sanitary materials, and medical devices, through its sales network. In the Lianghe area of the High-tech Zone, relying on the existing plant of Shandong Mingren Freda Co., Ltd., it has relocated and expanded six other companies to establish the first phase of the Shandong Freda Biopharmaceutical Industrial Park, covering nearly 300 mu.